Activation of rat macrophages by betafectin® PGG-glucan requires cross- linking of membrane receptors distinct from complement receptor three (CR3)

Journal of Leukocyte Biology

Volumn 64, Issue 3, 1998, Pages 337-344

  Michalek, Michael ^a   Melican, David ^a   Brunke Reese, Deborah ^a   Langevin, Matthew ^a   Lemerise, Kristen ^a   Galbraith, William ^a   Patchen, Myra ^a   Mackin, William ^a  

^a Alpha Beta Technology Inc   (United States)

Author keywords

CR3 receptor; NR8383 cell line; Respiratory burst; Tumor necrosis factor ; glucan

Indexed keywords

BETA GLUCAN; COMPLEMENT COMPONENT C3 RECEPTOR; GLUCAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RAT; RESPIRATORY BURST;

ANIMALIA;

EID: 0031656785     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.64.3.337     Document Type: Article

References (67)

1. Klis, F. M. (1994) Review: Cell wall assembly in yeast. Yeast 10, 851-869.
2. Cid, V. J., Duran, A., del Rey, F., Snyder, M. P., Nombela, C., Sanchez, M. (1995) Molecular basis of cell integrity and morphogenesis in Saccharomyces cerevisiae. Microbiol. Rev. 59, 345-386.
3. ® PGG-Glucan: A novel carbohydrate immunomodulator with anti-infective properties. J. Biotechnol. Healthcare 2, 207-222.
4. Bohn, J. A. Q., BeMiller, J. N. (1995) (1→3)-β-D-glucans as biological response modifiers: A review of structure-functional activity relationships. Carbohydr. Polymers 28, 3-14.
5. Williams, D. L., Mueller, A., Browder, W. (1996) Glucan-based macrophage stimulators: A review of their anti-infective potential. Clin. Immunother. 5, 392-399.
6. Stone, B. A., Clarke, A. E. (1992) (1→3)-β-Glucans in animal defense mechanisms. In Chemistry and Biology of (1→3)-β-Glucans. (La Trobe, ed.) Victoria, Australia: University Press, 525-564.
7. Janusz, M. J., Austen, K. F., Czop, J. K. (1987) Lysosomal enzyme release from human monocytes by particulate activators is mediated by β-glucan inhibitable receptors. J. Immunol. 138, 3897-3901.
8. Bogwald, J., Johnson, E., Hoffman, J., Seljelid, R. (1984) Lysosomal glycosidases in mouse peritoneal macrophages stimulated in vitro with soluble and insoluble glycans. J. Leukoc. Biol. 35, 357-371.
9. Lew, D., Leslie, C., Riches, D., Henson, P. (1986) Induction of macrophage lysosomal hydrolase synthesis and secretion by β-1,3-glucan. Cell. Immunol. 50, 71-80.
10. Abel, G., Czop, J. K. (1992) Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1β. Int. J. Immunopharmacol. 14, 1363-1373.
11. 2 production but not antigen-presenting function. J. Leukoc. Biol. 49; 342-351.
12. Rasmussen, L., Seljelid, R. (1989) The modulatory effect of lipoproteins on the release of interleukin-1 by human peritoneal macrophages stimulated with β-1,3-D-polyglucose derivatives. Scand. J. Immunol 29, 477-484.
13. Williams, J. D., Czop, J. K., Austen, K. F. (1984) Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J. Immunol. 132, 3034-3040.
14. Czop, J. K., Austen, K. F. (1985) Generation of leukotrienes by human monocytes upon stimulation of their β-glucan receptor during phagocytosis. Proc. Natl. Acad. Sci. USA 82, 2751-2755.
15. Sherwood, E. R., Williams, D. L., McNamee, R. B., Jones, E. L., Browder, I. W., Diluzio, N. R. (1987) Enhancement of interleukin-1 and interleukin-2 production by soluble glucan. Int. J. Immunopharmacol. 9, 261-267.
16. Kilgore, K. S., Imlay, M. M., Szaflarski, J. D., Silverstein, F. S., Malani, A. N., Evans, V. M., Warren, J. J. (1997) Neutrophils and reactive oxygen intermediates mediate glucan-induced pulmonary granuloma formation through local induction of monocyte chemoattractant protein-1. Lab. Invest. 76, 191-201.
17. Kulicke, W. M., Lettau, A. I., Thielking, H. (1997) Correlation between immunological activity, molar mass, and molecular structure of different (1→3)-β-D-glucans. Carbohyd. Res. 297, 135-143.
18. Gallin, E. K., Green, S. W., Patchen, M. L. (1992) Comparative effects of particulate and soluble glucan on macrophages of C3H/HeN and C3H/HeJ mice. Int. J. Immunopharmacol. 14, 173-183.
19. 4 production. J. Immunol. 141, 3170-3176.
20. 4. Scand. J. Immunol. 32, 333-340.
21. Onderdonk, A. B., Cisneros, R. L., Hinkson, P., Ostroff, G. R. (1992) Anti-infective effect of poly-β1-6-glucotriosyl-β1-3-glucopyranose glucan in vivo. Infect. Immun. 60, 1642-1647.
22. Stashenko, P., Wang, C. Y., Riley, E., Wu, Y., Ostroff, G., Niederman, R. (1995) Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG-glucan. J. Dent. Res. 74, 323-330.
23. Cisneros, R. L., Gibson, F. C., Tzianabos, A. O. (1996) Passive transfer of poly-(1-6)-β-glucotriosyl-(1-3)-β-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis. Infect. Immun. 64, 2201-2205.
24. Liang, J., Melican, D., Cafro, L., Palace, G., Fisette, L., Armstrong, R., Patchen, M. L. (1998) Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased oxidative burst activity. Int. J. Immunopharmacol., in press.
25. Kernodle, D. S., Gates, H., Kaiser, A. B. (1998) Prophylactic anti-infective activity of Poly-[1-6]-β-D-glucopyranosyl-[1-3]-β-D-glucopyranose glucan in a guinea pig model of staphylococcal wound infection. Antimicrob. Agents Chemother. 42, 545-549.
26. Babineau, T., Marcello, P., Swails, W., Kenler, A., Wakshull, E., Oldman, F. (1994) Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-Glucan) in high risk surgical patients. Ann. Surg. 220, 601-609.
27. Babineau, T. J., Hackford, A., Kenler, A., Bistrian, B., Forse, R. A., Fairchild, P. G., Heard, S., Keroack, M., Caushaj, P., Benotti, P. (1994) A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-Glucan) in high risk surgical patients. Arch. Surg. 129, 1204-1210.
28. Adams, D. S., Pero, S. C., Petro, J. B., Nathans, R., Mackin, W. M., Wakshull, E. (1997) PGG-glucan activates NF-κB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J. Leukoc. Biol. 62, 865-873.
29. Poutsiaka, D. D., Mengozzi, M., Vannier, E., Sinha, B., Dinarello, C. A. (1993) Crosslinking of the β-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production. Blood 82; 3695-3700.
30. ® PGG-glucan alone and in combination with granulocyte colony-stimulating factor. Stem Cells 16, 208-217.
31. Jamas, S., Rha, C. R., Sinskey, A. J. (1989) Glucan compositions and process for preparation thereof. US Patent number 4,810,646.
32. Jamas, S., Easson, D. D., Ostroff, G. (1994) Novel glucan preparation. International patent publication number W094/04163.
33. Wyatt, D. W. (1993) Light scattering and the absolute characterization of macromolecules. Analytica Chemica Acta 272, 1-40.
34. Dubois, M., Gilles, R. A., Hamilton, J. R., Rebers, P. A., Smith, F. (1956) Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350-365.
35. Dische, Z. (1962) Color reactions of carbohydrates. Meth. Carbohydr. Chem. 1, 478-514.
36. Robinson, A. P. , White, T. M., Mason, D. W. (1986) Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunol. 57, 239-247.
37. Damoiseaux, J. G. M. C., Dopp, E. A., Neefjes, J. J., Beelan, R. H. J., Dijkstra, C. D. (1989) Heterogeneity of macrophages in the rat evidenced by variability in determinants: Two new anti-rat macrophage antibodies against a heterodimer of 160 and 95 kD (CD11/CD18). J. Leukoc. Biol. 46, 560-564.
38. Helmke, R. J., Boyd, R. L., German, V. F., Mangos, J. A. (1987) From growth factor dependence to growth factor responsiveness: The genesis of an alveolar macrophage cell line. In Vitro Cell. Dev. Biol 23, 567-574.
39. Helmke, R. J., German, V. F., Mangos, J. A. (1989) A continuous alveolar macrophage cell line: Comparisons with freshly derived alveolar macrophages. In Vitro Cell. Dev. Biol. 25, 44-48.
40. Hidalgo, H. A., Helmke, R. J., German, V. F., Mangos, J. A. (1992) The effects of cyclosporine and dexamethasone on an alveolar macrophage cell line (NR8383). Transplantation 53, 620-623.
41. Wong. S., Shan, S. (1991) Chemistry of Protein Conjugation and Crosslinking. Boca Raton, FL: CRC Press.
42. Universal Covalent, Corning Technical Bulletin #IM-UNIV-COV, Corning Science Product Division. Acton, MA.
43. Mayo, L. A., Curnutte, J. T. (1990) Rinetic microplate assay for superoxide production by neutrophils and other phagocytic cells. Meth. Enzymol. 186, 567-575.
44. Ross, G. D., Cain, J. A., Myones, B. L., Newman, S. L., Lachmann, P. J. (1987) Specificity of membrane complement type three (CR3) for β-glucans. Complement 4, 61-74.
45. Sakurai, T., Suzuki, I., Kinoshita, A., Oikawa, S., Masuda, A., Ohsawa, M., Yodomae, T. (1991) Effect of intraperitoneally administered β-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages. Chem. Pharm. Bull. 39, 214-217.
46. Cain, J. A., Newman, S. L., Ross, G. D. (1987) Role of complement receptor type three and serum opsonins in the PMN response to yeast. Complement 4, 75-86.
47. Liles, W. C., Ledbetter, J. A., Waltersdorph, A. W., Klebanoff, S. J. (1995) Crosslinking of CD45 enhances activation of the respiratory burst in response to specific stimuli in human phagocytes. J. Immunol. 155, 2175-2184.
48. Webb, D. S. A., Shimizu, Y., Seventer, G. A. V., Shaw, S., Gerrard, T. L. (1990) LFA-3, CD44, and CD45: Physiologic triggers of human monocyte TNF and IL-1 release. Science 249, 1295-1297.
49. Vassali, P. (1993) The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10, 411-452.
50. 3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 134, 3307-3315.
51. Thornton, B. P., Vetvicka, V. Pitman, M., Goldman, R. C., Ross, G. D. (1096) Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156, 1235-1246.
52. Henson, P. M. (1971) Interaction of cells with immune complexes: Adherence, release of constitutents, and tissue injury. J. Exp. Med. 134, 114s-135s.
53. Takemura, R., Stenberg, P. E., Bainton, D. F., Werb, Z. (1986) Rapid redistribution of clathrin onto macrophage plasma membranes in response to Fc receptor-ligand interaction during frustrated phagocytosis. J. Cell. Biol. 102, 55-69.
54. Weiss, S. J., Ward, P. (1982) Immune complex induced generation of oxygen metabolites by human neutrophils. J. Immunol. 145, 3062-3067.
55. Tenner A. J., Cooper, N. R. (1982) Stimulation of a human polymorphonuclear leukocyte oxidative response by the Clq subunit of the first complement component. J. Immunol. 128, 2547-2552.
56. Arend, W. P., Joslin, F. G., Massoni, R. J. (1985) Effects of immune complexes on production by human monocytes of interleukin-1 or an interleukin-1 inhibitor. J. Immunol. 134, 3868-3875.
57. Seljelid, R., Rasmussen, L. -T., Larm, O., Hoffman, J. (1987) The protective effect of β1-3D-glucan derivatized plastic beads against Escherichia coli infection in mice. Scand. J. Immunol. 25, 55-60.
58. 2 and interleukin-1 by mouse peritoneal macrophages stimulated with β-1,3-D-glucan derivatized plastic beads. Scand. J. Immunol. 26, 731-736.
59. Rasmussen, L. -T., Seljelid, R. (1990) Dynamics of blood components and peritoneal fluid during treatment of marine E. coli sepsis with β-1.3-D-polyglucose derivatives. I. Cells. Scand. J. Immunol. 32: 321-331.
60. Seljelid, R., Gao, Q., Berge, A., Ugelstad, J. (1997) Biological effects of the immunomodulator β1-3D polyglucose are strongly potentiated by conjugation to biodegradable microbeads. Scand. J. Immunol. 48, 683-687.
61. 3. Immunol. 63, 319-324.
62. 2, Mac-1). J. Immunol. 151, 3324-3336.
63. Goldman, R. (1988) Characteristics of the β-glucan receptor of murine macrophages. Exp. Cell Res. 174, 481-490.
64. Czop, J. K., Kay, J. (1991) Isolation and characterization of β-glucan receptors on human mononuclear phagocytes. J. Exp. Med. 173, 1511-1520.
65. Szabo, T., Kadish, J. L., Czop, J. K. (1995) Biochemical properties of the ligand-binding 20-kDa subunit of the β-glucan receptors on human mononuclear phagocytes. J. Biol. Chem. 270, 2145-2151.
66. Konopski, Z., Smedsrod, B., Seljelid, R., Eskeland, T. (1994) A novel immunomodulator soluble aminated β-1,3-D-glucan: Binding characteristics to mouse peritoneal macrophages. Biochem. Biophys. Acta 1221 61-65.
67. Muller, A., Rice, P. J., Ensley, H. E., Coogan, P. S., Kalbfleisch, J. H., Kelley, J. L., Love, E. J., Portera, C. A., Ha, T., Browder, I. W., Williams, D. L. (1996) Receptor binding and internalization of a water-soluble (1→3)-β-D-glucan biological response modifier in two monocyte/macrophage cell lines. J. Immunol. 156, 3418-3425.